Prevention & lipids

Rationale and design of VICAD-RISK study: Visualization of coronary artery disease for modification of risk factors

Am Heart JPublished multicenter randomized trial

Study context

Population
Statin naïve patients suspected of chronic coronary syndrome with a new diagnosis of NOCAD determined by first-line coronary computed tomography angiography (CTA)planned, to be randomized 1:1:1
Participants
273 patients
Planned comparison
Visualization of personal CTA images to patients with a new diagnosis of NOCAD
Primary endpoint
reduction of low-density lipoprotein (LDL) cholesterol
Follow-up
12 months
Methodological detailsDanish
  • Danish

No results yet. This paper sets out the design of a trial; its results are to come.

Original publication

Rationale and design of VICAD-RISK study: Visualization of coronary artery disease for modification of risk factors. Am Heart J. Published 3 April 2025. doi:10.1016/j.ahj.2025.04.002

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.